NEW YORK (360Dx) – Sciex said today that it has received de novo US Food and Drug Administration clearance for its mass spec-based Vitamin D assay kit.

The test, which will be offered through the company's Sciex Diagnostics division, is the only FDA-cleared LC-MS-based Vitamin D assay kit currently on the market, Sciex said.

Called the Vitamin D 200M Assay, the kit is meant to be run exclusively on the Sciex Topaz System, an integrated LC-MS platform running Sciex's ClearCore MD clinical software.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.